Literature DB >> 7398750

Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants.

H Lagercrantz, A Rane, R Tunell.   

Abstract

The relation between plasma concentration of theophylline and number of apnea preterm infants was studied in six patients. The apnea frequency was monitored after cessation of theophylline treatment and plotted against the log plasma concentration of theophylline. It was calculated that at an average plasma concentration of 40 mumol/l (7.25 micrograms/ml) the preterm infants had two or less apnea per 12 h. On the basis of our results we suggest that 40 mumol/l is the minimum plasma concentration of theophylline for optimal effect on apnea in preterm infants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398750     DOI: 10.1007/bf00561480

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Treatment of severe apnea in prematures with orally administered theophylline.

Authors:  R Uauy; D L Shapiro; B Smith; J B Warshaw
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

2.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

3.  Gas-chromatographic micro-scale procedure for theophylline, with use of a nitrogen-sensitive detector.

Authors:  C J Least; G F Johnson; H M Solomon
Journal:  Clin Chem       Date:  1976-06       Impact factor: 8.327

4.  The effect of inhalation of high and low concentrations of oxygen on the respiration of the premature infant.

Authors:  K W CROSS; T E OPPE
Journal:  J Physiol       Date:  1952-05       Impact factor: 5.182

5.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

6.  Apnoeic attacks in the newborn treated with aminophylline.

Authors:  J A Kuzemko; J Paala
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

7.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

8.  Prevention of apnea and bradycardia in low-birthweight infants.

Authors:  D C Shannon; F Gotay; I M Stein; M C Rogers; I D Todres; F M Moylan
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

9.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

10.  Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.

Authors:  J V Aranda; W Gorman; H Bergsteinsson; T Gunn
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

View more
  3 in total

Review 1.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

2.  Influence of food intake on bioavailability of theophylline in premature infants.

Authors:  G Heimann; J Murgescu; U Bergt
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Pharmacokinetics of diuretics and methylxanthines in the neonate.

Authors:  J V Aranda; T Turmen; B I Sasyniuk
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.